GPX4 and cancer: In addition, drug-resistant “persister” cancer cells are also highly dependent on GPX4 for survival [8, 9] and this has led to substantial interest in targeting GPX4 to induce ferroptosis as a therapeutic approach in cancer, though GPX4 inhibitors suitable for clinical use have not yet been reported.